Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94362Research ArticleSeveral cases of ticagrelor application on conducting fibrinolytic therapy of ST elevation myocardial infarctionPochinkaI. Gpochinka4@ya.ruBotovaS. N-StronginL. G-SuvorovA. V-D'iachkovaK. I-PimankinaM. S-Nizhny Novgorod State Medical Academy of the Ministry of Health of the Russian FederationCity Clinical Hospital №13City Clinical Hospital №39151020151710434428122021Copyright © 2015, Consilium Medicum2015There have been found limited number of publications devoted to ticagrelor application as a part of antiplatelet treatment on conducting systemic thrombolysis in patients with ST elevation myocardial infarction. The paper showed the analysis of such therapy safety, based on hospital data registers; we found out 54 cases of ticagrelor application within the first 24 hours after thrombolysis. The usage of ticagrelor was not accompanied by an increased risk of bleeding complications in comparison with standard clopidogrel therapy.myocardial infarctionthrombolytic therapyticagrelorинфаркт миокардатромболитическая терапиятикагрелор[Wallentin L, Becker R.C, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-57.][Steg G, James S.K, Atar D et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619.][Goudevenos J, Ntalas I, Xanthopoulou I et al. Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis. J Thromb Thrombolysis 2014; 37: 356-7.]